Phosphoribosyltransferase
From Proteopedia
(Difference between revisions)
| Line 47: | Line 47: | ||
*Orotate phosphoribosyltransferase complex | *Orotate phosphoribosyltransferase complex | ||
| - | **[[1sto]]– StOPRT + OMP<br /> | + | **[[1sto]] – StOPRT + OMP<br /> |
**[[2prz]] - yOPRT + OMP<br /> | **[[2prz]] - yOPRT + OMP<br /> | ||
**[[2qcn]], [[2wns]], [[3l0k]], [[3l0n]], [[3mo7]] – hOPRT + UMP derivative<br /> | **[[2qcn]], [[2wns]], [[3l0k]], [[3l0n]], [[3mo7]] – hOPRT + UMP derivative<br /> | ||
| Line 53: | Line 53: | ||
**[[4hib]], [[4hkp]] - hOPRT + inhibitor<br /> | **[[4hib]], [[4hkp]] - hOPRT + inhibitor<br /> | ||
**[[4rv4]] - BaOPRT + PRPP<BR /> | **[[4rv4]] - BaOPRT + PRPP<BR /> | ||
| - | **[[4wml]], [[4wn3] - yOPRT + PRPP<BR /> | + | **[[4wml]], [[4wn3]] - yOPRT + PRPP<BR /> |
**[[1opr]], [[1lh0]] - StOPRT + orotate + PRPP<BR /> | **[[1opr]], [[1lh0]] - StOPRT + orotate + PRPP<BR /> | ||
**[[2ps1]] - yOPRT + orotate + PRPP<BR /> | **[[2ps1]] - yOPRT + orotate + PRPP<BR /> | ||
Revision as of 21:02, 13 October 2017
| |||||||||||
3D structures of phosphoribosyltransferase
Updated on 13-October-2017
References
- ↑ Sculley DG, Dawson PA, Emmerson BT, Gordon RB. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum Genet. 1992 Nov;90(3):195-207. PMID:1487231
- ↑ Gonzalez-Segura L, Witte JF, McClard RW, Hurley TD. Ternary complex formation and induced asymmetry in orotate phosphoribosyltransferase. Biochemistry. 2007 Dec 11;46(49):14075-86. Epub 2007 Nov 20. PMID:18020427 doi:10.1021/bi701023z
- ↑ Foster AC, Whetsell WO Jr, Bird ED, Schwarcz R. Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res. 1985 Jun 17;336(2):207-14. PMID:3159462
- ↑ Carter D, Donald RG, Roos D, Ullman B. Expression, purification, and characterization of uracil phosphoribosyltransferase from Toxoplasma gondii. Mol Biochem Parasitol. 1997 Aug;87(2):137-44. PMID:9247925
- ↑ . PMID:121011881
- ↑ Castell A, Short FL, Evans GL, Cookson TV, Bulloch EM, Joseph DD, Lee CE, Parker EJ, Baker EN, Lott JS. Substrate capture mechanism of Mycobacterium tuberculosis anthranilate phosphoribosyltransferase provides a mode for inhibition. Biochemistry. 2013 Jan 30. PMID:23363292 doi:http://dx.doi.org/10.1021/bi301387m
- ↑ Pedreno S, Pisco JP, Larrouy-Maumus G, Kelly G, de Carvalho LP. Mechanism of feedback allosteric inhibition of ATP phosphoribosyltransferase. Biochemistry. 2012 Oct 9;51(40):8027-38. doi: 10.1021/bi300808b. Epub 2012 Sep, 27. PMID:22989207 doi:http://dx.doi.org/10.1021/bi300808b
- ↑ Galassi L, Di Stefano M, Brunetti L, Orsomando G, Amici A, Ruggieri S, Magni G. Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis. Biochimie. 2012 Feb;94(2):300-9. doi: 10.1016/j.biochi.2011.06.033. Epub 2011 Jul, 3. PMID:21742010 doi:http://dx.doi.org/10.1016/j.biochi.2011.06.033
- ↑ Imai S. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr Pharm Des. 2009;15(1):20-8. PMID:19149599
- ↑ Tohyama J, Nanba E, Ohno K. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet. 1994 Feb;93(2):175-81. PMID:8112742
- ↑ Montecucco F, Cea M, Cagnetta A, Damonte P, Nahimana A, Ballestrero A, Del Rio A, Bruzzone S, Nencioni A. Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders. Curr Top Med Chem. 2013;13(23):2930-8. PMID:24171767
- ↑ Gonzalez-Segura L, Witte JF, McClard RW, Hurley TD. Ternary complex formation and induced asymmetry in orotate phosphoribosyltransferase. Biochemistry. 2007 Dec 11;46(49):14075-86. Epub 2007 Nov 20. PMID:18020427 doi:10.1021/bi701023z

